Amelioration of diabetic nephropathy by dried Rehmanniae Radix (Di Huang) extract

American Journal of Chinese Medicine

Volumn 32, Issue 6, 2004, Pages 829-839

  Yokozawa, Takako ^a   Kim, Hyun Young ^a   Yamabe, Noriko ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

5 Hydroxymethylfurfural; Diabetic nephropathy; Dried Rehmanniae Radix; Rat; Thiobarbituric acid reactive substance

Indexed keywords

5 HYDROXYMETHYLFURFURAL; CHINESE DRUG; GLUCOSE; PLANT EXTRACT; REHMANNIA EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY PARENCHYMA; MALE; NEPHRECTOMY; NONHUMAN; PLANT ROOT; RAT; REHMANNIA; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; KIDNEY; MALE; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; REFERENCE VALUES; REHMANNIA;

EID: 10944225937     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X04002442     Document Type: Article

References (29)

1. Andreoli, S.P. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr. Nephrol. 5: 733-742, 1991.
2. Cotter, M.A., A. Love, M.J. Watt, N.E. Cameron and K.C. Dines. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 38: 1285-1294, 1995.
3. Cross, C.E., B. Halliwell, E.T. Borish, W.A. Pryor, B.N. Ames, R.L. Saul, J.M. McCord and D. Harman. Oxygen radicals and human disease. Ann. Intern. Med. 107: 526-545, 1987.
4. Crowley, S.T., M. Brownlee, D. Edelstein, J.A. Satriano, T. Mori, P.C. Singhal and D.O. Schlondorff. Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40: 540-547, 1991.
5. Gugliucci, A. and M. Bendayan. Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39: 149-160, 1996.
6. Hasslacher, C., A. Bostedt-Kiesel, H.P. Kempe and P. Wahl. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 1051-1056, 1993.
7. Kawada, J. New hypotheses for the mechanisms of streptozotocin and alloxan inducing diabetes mellitus. Yakugaku Zasshi 112: 773-791, 1992.
8. Kimura, M., J. Suzuki and T. Koizumi. Glucose tolerance curves in genetically diabetic KK-CAy mice: The pharmacokinetic analysis for humping effect. J. Pharm. Dyn. 4: 149-161, 1981.
9. Kubo, M., T. Asano, H. Shiomoto and H. Matsuda. Studies on Rehmanniae Radix. I. Effect of 50% ethanolic extract from steamed and dried Rehmanniae Radix on homorheology in arthritic and thrombosic rats. Biol. Pharm. Bull. 17: 1282-1286, 1994.
10. Lewis, E.J., L.G. Hunsicker, R.P. Bain and R.D. Rohde. The effect of angiotensin-converting- enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329: 1456-1462, 1993.
11. Li, X.P. Experimental study on anti-senility of the 4 famous Chinese herbs produced in Huaiqing area. Zhong Xi Yi Jie He Za Zhi 11: 486-487, 1991.
12. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
13. Luno, J., S.G. De Vinuesa, F. Gomez-Campdera, I. Lorenzo and F. Valderrabano. Effects of antihypertensive therapy on progression of diabetic nephropathy. Kidney Int. 54: S-112-S-119, 1998.
14. Makita, Z., S. Radoff, E.J. Rayfield, Z. Yang, E. Skolnik, V. Delaney, E.A. Friedman, A. Cerami and H. Vlassara. Advanced glycosylation end products in patients with diabetic nephropathy. N. Engl. J. Med. 325: 836-842, 1991.
15. McFarland, K.F., E.W. Catalano, J.F. Day, S.R. Thorpe and J.W. Baynes. Nonenzymatic glucosylation of serum proteins in diabetes mellitus. Diabetes 28: 1011-1014, 1979.
16. Miyata, T., Y. Wada, Z. Cai, Y. Iida, K. Horie, Y. Yasuda, K. Maeda, K. Kurokawa and C. van Ypersele de Strihou. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 51: 1170-1181, 1997.
17. Mylonas, C. and D. Kouretas. Lipid peroxidation and tissue damage. In Vivo 13: 295-309, 1999.
18. Naito, C. and T. Yamanaka. Atherosclerotic disorder and lipid peroxidation. Jpn. J. Geriatr. 15: 187-191, 1978.
19. Nielsen, B. and A. Flyvbjerg. Calcium channel blockers - the effect on renal changes in clinical and experimental diabetes: An overview. Nephrol. Dial. Transplant. 15: 581-585, 2000.
20. Prasad, K., S.V. Mantha, A.D. Muir and N.D. Westcott. Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol. Cell. Biochem. 206: 141-149, 2000.
21. Sato, K., A. Inazu, S. Yamaguchi, T. Nakayama, Y. Deyashiki, H. Sawada and A. Hara. Monkey 3-deoxyglucosone reductase: Tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase. Arch. Biochem. Biophys. 307: 286-294, 1993.
22. II in neonatal mesangial cells. Am. J. Physiol. Renal Physiol. 278: F676-F683, 2000.
23. Sebekova, K., R. Schinzel, G. Munch, Z. Krivosikova, R. Dzurik and A. Heidland. Advanced glycation end-product levels in subtotally nephrectomized rats: Beneficial effects of angiotensin II receptor 1 antagonist losartan. Miner. Electrolyte Metab. 25: 380-383, 1999.
24. Shimoike, T., T. Inoguchi, F. Umeda, H. Nawata, K. Kawano and H. Ochi. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. Metabolism 49: 1030-1035, 2000.
25. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med. 342: 381-389, 2000.
26. Uchiyama, M. and M. Mihara. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86: 271-278, 1978.
27. Vlassara, H., R. Bucala and L. Striker. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70: 138-151, 1994.
28. Weiss, M.F., R.A. Rodby, A.C. Justice, D.E. Hricik and The Collaborative Study Group. Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Kidney Int. 54: 193-202, 1998.
29. Yokozawa, T., T. Nakagawa, K. Wakaki and F. Koizumi. Animal model of diabetic nephropathy. Exp. Toxic. Pathol. 53: 359-363, 2001.